A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1999
12/09/1999	WO1999051262A3 Use of igfi for treating articular cartilage disorders
12/09/1999	WO1999051260A3 Treatment of cardiac hypertrophy
12/09/1999	WO1999051256A3 Use of l-glu-l-trp in the treatment of hiv infection
12/09/1999	WO1999050290A9 Para-poxvirus-coded vascular endothelial cell growth factor (ppv-vegf)
12/09/1999	WO1999049885A3 The use of isolated domains of type iv collagen to modify cell and tissue interactions
12/09/1999	WO1999048917A3 Formulation having a papilloma virus-specific protein, and the production and use thereof
12/09/1999	WO1999047678A3 Interferon alpha plasmids and delivery systems, and methods of making and using the same
12/09/1999	WO1999046367A3 Methods of diagnosis and triage using cell activation measures
12/09/1999	WO1999045117A3 Interferon, ifn-hy and uses thereof
12/09/1999	WO1999038973A3 Compounds for therapy and diagnosis of lung cancer and methods for their use
12/09/1999	WO1999036536A3 Methods and compositions to alter tissue susceptibility to immune injury, to programmed cell death, and to clearance by the reticuloendothelial system
12/09/1999	WO1999024066A3 Methods and compositions for enhancing immune response and for the production of in vitro mabs
12/09/1999	WO1998005673A8 Methods for purifying nucleic acids
12/09/1999	DE19825621A1 Protein zur Regulation von Apoptose Protein for regulation of apoptosis
12/09/1999	DE19825494A1 Neuer Angiotensin Rezeptor, Herstellung und Verwendung desselben The same new angiotensin receptor preparation and use
12/09/1999	DE19825447A1 Neue Insulinanaloga mit erhöhter Zinkbildung New insulin analogues with increased zinc Education
12/09/1999	DE19824811A1 Verfahren zur Auslösung von Apoptose in Zellen Method for triggering of apoptosis in cells
12/09/1999	DE19822711A1 Sensorsystem mit Portkörper Sensor system with port body
12/09/1999	CA2334171A1 Gene therapy method
12/09/1999	CA2333975A1 Method of inhibiting angiogenesis and tumor growth and preventing tumor growth and metastases
12/09/1999	CA2333776A1 Composition based on pentoxifylline and anticytokin
12/09/1999	CA2333751A1 Membrane-permeable inhibitor of dynamin-mediated endocytosis
12/09/1999	CA2333698A1 Pipecolic acid derivative hair growth compositions and uses
12/09/1999	CA2333315A1 Use of cyclosporins in the treatment of inflammatory autoimmune diseases
12/09/1999	CA2333063A1 Recombinant human interferon beta-1a (ifn-beta-1a) formulation
12/09/1999	CA2331370A1 Protein oligomer compositions comprising endostatin protein and methods of using the same
12/09/1999	CA2330833A1 Human minor vault protein p193
12/09/1999	CA2330567A1 Lysine containing peptides for treatment of heart disease
12/09/1999	CA2330227A1 Method for triggering apoptosis in cells
12/09/1999	CA2330191A1 Protease inhibitor peptides
12/09/1999	CA2330179A1 Human homologue of unc-53 protein of c. elegans
12/09/1999	CA2330172A1 Prosthetic implant and methods of use for therapeutic gene expression
12/09/1999	CA2330171A1 Human protein c polypeptide
12/09/1999	CA2329940A1 Use of genetically engineered antibodies to cd38 to treat multiple myeloma
12/09/1999	CA2329934A1 Methods of altering cardiac cell phenotype
12/09/1999	CA2329527A1 Endometriosis-associated gene
12/09/1999	CA2329512A1 Il-6/sil-6r complex for promotion of liver functions
12/09/1999	CA2329247A1 Amino-modified ribozymes
12/09/1999	CA2329146A1 Carbamoyl phosphate synthase homolog
12/09/1999	CA2329132A1 Method of designing agonists and antagonists to egf receptor family
12/09/1999	CA2328891A1 G-protein coupled receptor, named 2871 receptor
12/09/1999	CA2299389A1 Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors
12/08/1999	EP0962531A2 Interferon-gamma production inducing isolated polypeptide fragment and an isolated DNA fragment encoding said polypeptide
12/08/1999	EP0962530A2 Gene sequence encoding for the angiopoietin related protein scarface 1
12/08/1999	EP0962529A1 Synthesis of human procollagens and collagens in recombinant DNA systems
12/08/1999	EP0962467A1 Antibody against human parathormone related peptides
12/08/1999	EP0962466A1 Angiopoietin related gene sequence scarface 3
12/08/1999	EP0961833A1 Human plasma hyaluronidase
12/08/1999	EP0961831A1 Human endokine alpha
12/08/1999	EP0961824A1 Method of activating dendritic cells
12/08/1999	EP0961801A1 Monomers derived from hydroxy acids and polymers prepared therefrom
12/08/1999	EP0961782A1 Human tumor necrosis factor receptor-like 2
12/08/1999	EP0961781A1 Ama
12/08/1999	EP0961780A1 Protein markers for lung cancer and use thereof
12/08/1999	EP0961778A1 3-hydroxyacyl-coa dehydrogenase from staphylococcus aureus
12/08/1999	EP0961619A1 Hydrolyzable prodrugs for delivery of anticancer drugs to metastatic cells
12/08/1999	EP0961547A1 NEUTRALIZATION-SENSITIVE EPITOPES OF $i(CRYPTOSPORIDIUM PARVUM)
12/08/1999	EP0824545B1 Peptide compositions with growth factor-like activity
12/08/1999	EP0786001A4 Chemokine-like proteins and methods of use
12/08/1999	EP0775158B1 Cyclopeptolides
12/08/1999	EP0695351B1 Isolation, selection and propagation of animal transgenic stem cells
12/08/1999	EP0640101B1 Methods and reagents for diagnosis of autoantibodies
12/08/1999	EP0634934B1 Use of dietary whey proteins for the treatment of hiv-seropositive individuals
12/08/1999	EP0628078B1 Multivalent single chain antibodies
12/08/1999	EP0600970B1 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity
12/08/1999	EP0522078B1 Gp75 as a tumor vaccine for melanoma
12/08/1999	CN1238010A Bovine lactation associated immunotropic protein (CD14), encoding gene and application in B cell activation
12/08/1999	CN1237983A Antibody against human parathormone related peptides
12/08/1999	CN1237982A Soluble polypeptides
12/08/1999	CN1237981A Peptide diagnostic and therapeutic agent for autoimmune diseases
12/08/1999	CN1237980A Polypptides comprising GAX protein domains, involved in repressing transcription and/or interacting with other proteins, corresponding nucleic acid and their use
12/08/1999	CN1237979A Conformationally constrained LH-RH analogues, their ues and pharmaceutical composisions containing them
12/08/1999	CN1237978A N (aryl/heteroaryl) amino acid derivatives, pharmaceutical compositions comprising same, and method for inhibiting 'beta'-amyloid peptide release and/or its synthesis by use of such compounds
12/08/1999	CN1237910A Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and use of anti-lymphotoxin ligand antibodies
12/08/1999	CN1237903A Method for preparing malonate methylidene nanoparticles, nanoparticles optionally containing one or several biologically active molecules
12/08/1999	CN1237881A Method and compositions for increasing anaerobic working capacity in tissues
12/08/1999	CN1237633A New structured L-asparaginase engineering bacterium and its production culture
12/08/1999	CN1047204C 生产重组人体乳铁蛋白 Production of recombinant human lactoferrin
12/07/1999	US5998602 RNase L activators and antisense oligonucleotides effective to treat RSV infections
12/07/1999	US5998601 VR-2332 viral nucleotide sequence and methods of use
12/07/1999	US5998600 β-catenin, TCF-4, and APC interact to prevent cancer
12/07/1999	US5998598 Immunoadhesins and methods of production and use thereof
12/07/1999	US5998589 Method of purifying human factor VIII
12/07/1999	US5998588 Interactive molecular conjugates
12/07/1999	US5998587 Anti-cyanovirin antibody
12/07/1999	US5998586 Interleukin-5 specific recombinant antibodies
12/07/1999	US5998584 Reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
12/07/1999	US5998583 BH3 interacting domain death agonist
12/07/1999	US5998581 Reductive alkylation of glycopeptide antibiotics
12/07/1999	US5998579 Epimorphin antagonist and process for producing it
12/07/1999	US5998474 Reduction of oxygen free radicals; nervous system disorders,cardiovascular disorders
12/07/1999	US5998473 Analgesic use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester derivatives
12/07/1999	US5998470 Osteoporosis; oral diseases; antiarthritic agents
12/07/1999	US5998447 Heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
12/07/1999	US5998408 Autoimmune diseases; antiinflammatory agents
12/07/1999	US5998383 Antitumor antisense sequences directed against ribonucleotide reductase
12/07/1999	US5998379 Serine protease inhibitors-proline analogs
12/07/1999	US5998378 Compounds having proteolytic inhibitory activity useful for treating diseases, particularly as applied to the treatment of sepsis, aids or autoimmune diseases, resulting from a decrease in the circulating level of mature protein hormones
12/07/1999	US5998377 Administration of lh-rh antagonist cetrorelix in combination with at least one .alpha.-reductase inhibitor; without the side effects associated with testosterone levels being in a castration range.
12/07/1999	US5998376 Substance P treatment for immunostimulation

1 ... 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 2466 ... 3163